ID   ROCK1_RAT               Reviewed;        1369 AA.
AC   Q63644; Q7TP31;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 203.
DE   RecName: Full=Rho-associated protein kinase 1;
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:Q13464};
DE   AltName: Full=Liver regeneration-related protein LRRG199;
DE   AltName: Full=Rho-associated, coiled-coil-containing protein kinase 1;
DE   AltName: Full=Rho-associated, coiled-coil-containing protein kinase I;
DE            Short=ROCK-I;
DE   AltName: Full=p150 RhoA-binding kinase ROK beta;
DE   AltName: Full=p160 ROCK-1;
DE            Short=p160ROCK;
GN   Name=Rock1; ORFNames=Ac2-154;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH RHOA; RHOB AND
RP   RHOC, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain, and Liver;
RX   PubMed=8816443; DOI=10.1128/mcb.16.10.5313;
RA   Leung T., Chen X.-Q., Manser E., Lim L.;
RT   "The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and
RT   is involved in the reorganization of the cytoskeleton.";
RL   Mol. Cell. Biol. 16:5313-5327(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RA   Xu C.S., Li W.Q., Li Y.C., Yang K.J., Yan H.M., Chang C.F., Zhao L.F.,
RA   Ma H., Wang L., Wang S.F., Han H.P., Wang G.P., Chai L.Q., Yuan J.Y.,
RA   Shi J.B., Rahman S., Wang Q.N., Zhang J.B.;
RT   "Liver regeneration after PH.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, ROLE IN SMOOTH MUSCLE CONTRACTION AND HYPERTENSION, AND
RP   INHIBITION BY Y-27632.
RX   PubMed=9353125; DOI=10.1038/40187;
RA   Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., Morishita T.,
RA   Tamakawa H., Yamagami K., Inui J., Maekawa M., Narumiya S.;
RT   "Calcium sensitization of smooth muscle mediated by a Rho-associated
RT   protein kinase in hypertension.";
RL   Nature 389:990-994(1997).
RN   [4]
RP   FUNCTION, INTERACTION WITH PPP1R12A, AND SUBCELLULAR LOCATION.
RX   PubMed=19131646; DOI=10.1161/circresaha.108.188524;
RA   Wang Y., Zheng X.R., Riddick N., Bryden M., Baur W., Zhang X., Surks H.K.;
RT   "ROCK isoform regulation of myosin phosphatase and contractility in
RT   vascular smooth muscle cells.";
RL   Circ. Res. 104:531-540(2009).
CC   -!- FUNCTION: Protein kinase which is a key regulator of the actin
CC       cytoskeleton and cell polarity (PubMed:19131646, PubMed:9353125).
CC       Involved in regulation of smooth muscle contraction, actin cytoskeleton
CC       organization, stress fiber and focal adhesion formation, neurite
CC       retraction, cell adhesion and motility via phosphorylation of DAPK3,
CC       GFAP, LIMK1, LIMK2, MYL9/MLC2, TPPP, PFN1 and PPP1R12A
CC       (PubMed:19131646, PubMed:9353125). Phosphorylates FHOD1 and acts
CC       synergistically with it to promote SRC-dependent non-apoptotic plasma
CC       membrane blebbing. Phosphorylates JIP3 and regulates the recruitment of
CC       JNK to JIP3 upon UVB-induced stress (By similarity). Acts as a
CC       suppressor of inflammatory cell migration by regulating PTEN
CC       phosphorylation and stability (By similarity). Acts as a negative
CC       regulator of VEGF-induced angiogenic endothelial cell activation.
CC       Required for centrosome positioning and centrosome-dependent exit from
CC       mitosis (By similarity). Plays a role in terminal erythroid
CC       differentiation (By similarity). Inhibits podocyte motility via
CC       regulation of actin cytoskeletal dynamics and phosphorylation of CFL1
CC       (By similarity). Promotes keratinocyte terminal differentiation (By
CC       similarity). Involved in osteoblast compaction through the fibronectin
CC       fibrillogenesis cell-mediated matrix assembly process, essential for
CC       osteoblast mineralization (By similarity). May regulate closure of the
CC       eyelids and ventral body wall by inducing the assembly of actomyosin
CC       bundles (By similarity). {ECO:0000250|UniProtKB:P70335,
CC       ECO:0000250|UniProtKB:Q13464, ECO:0000250|UniProtKB:Q8MIT6,
CC       ECO:0000269|PubMed:19131646, ECO:0000269|PubMed:9353125}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q13464};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17990;
CC         Evidence={ECO:0000250|UniProtKB:Q13464};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q13464};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46609;
CC         Evidence={ECO:0000250|UniProtKB:Q13464};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ACTIVITY REGULATION: Activated by RHOA binding. Inhibited by Y-27632.
CC       {ECO:0000269|PubMed:9353125}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with GEM, MYLC2B, RHOE,
CC       LIMK1, LIMK2, TSG101, CHORDC1, DAPK3, PFN1, PTEN and JIP3 (By
CC       similarity). Interacts with FHOD1 in a Src-dependent manner (By
CC       similarity). Interacts with ITGB1BP1 (via N-terminus and PTB domain)
CC       (By similarity). Interacts with RHOA (activated by GTP), RHOB, RHOC and
CC       PPP1R12A. Interacts with SHROOM3 (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q13464, ECO:0000269|PubMed:19131646,
CC       ECO:0000269|PubMed:8816443}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19131646}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome,
CC       centriole {ECO:0000269|PubMed:19131646}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:P70335}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P70335}. Cell projection, bleb
CC       {ECO:0000250|UniProtKB:P70335}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:P70335}. Cell membrane
CC       {ECO:0000250|UniProtKB:P70335}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:P70335}. Cell projection, ruffle
CC       {ECO:0000250|UniProtKB:P70335}. Note=A small proportion is associated
CC       with Golgi membranes (By similarity). Associated with the mother
CC       centriole and an intercentriolar linker (By similarity). Colocalizes
CC       with ITGB1BP1 and ITGB1 at the cell membrane predominantly in
CC       lamellipodia and membrane ruffles, but also in retraction fibers (By
CC       similarity). Localizes at the cell membrane in an ITGB1BP1-dependent
CC       manner (By similarity). {ECO:0000250|UniProtKB:P70335}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q63644-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q63644-2; Sequence=VSP_010449, VSP_010450;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, spleen, lung, liver,
CC       skeletal muscle, kidney and testis. {ECO:0000269|PubMed:8816443}.
CC   -!- DOMAIN: The C-terminal auto-inhibitory domain interferes with kinase
CC       activity. RHOA binding leads to a conformation change and activation of
CC       the kinase. Truncated ROCK1 is constitutively activated.
CC   -!- PTM: Autophosphorylated on serine and threonine residues.
CC   -!- PTM: Cleaved by caspase-3 during apoptosis. This leads to constitutive
CC       activation of the kinase and membrane blebbing (By similarity).
CC       {ECO:0000250}.
CC   -!- DISEASE: Note=May play a role in hypertension. Rock1-inhibitors lower
CC       the blood pressure in spontaneous hypertensive, renal hypertensive and
CC       deoxycorticosterone acetate-induced hypertensive rats, but not in
CC       normal rats.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U61266; AAB37571.1; -; mRNA.
DR   EMBL; AY325220; AAP92621.1; -; mRNA.
DR   RefSeq; NP_112360.1; NM_031098.1.
DR   AlphaFoldDB; Q63644; -.
DR   SMR; Q63644; -.
DR   BioGRID; 249634; 3.
DR   CORUM; Q63644; -.
DR   IntAct; Q63644; 1.
DR   MINT; Q63644; -.
DR   STRING; 10116.ENSRNOP00000047378; -.
DR   BindingDB; Q63644; -.
DR   ChEMBL; CHEMBL5509; -.
DR   iPTMnet; Q63644; -.
DR   PhosphoSitePlus; Q63644; -.
DR   jPOST; Q63644; -.
DR   PaxDb; 10116-ENSRNOP00000047378; -.
DR   PeptideAtlas; Q63644; -.
DR   UCSC; RGD:620424; rat. [Q63644-1]
DR   AGR; RGD:620424; -.
DR   RGD; 620424; Rock1.
DR   eggNOG; KOG0612; Eukaryota.
DR   InParanoid; Q63644; -.
DR   OrthoDB; 4221785at2759; -.
DR   PhylomeDB; Q63644; -.
DR   Reactome; R-RNO-111465; Apoptotic cleavage of cellular proteins.
DR   Reactome; R-RNO-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-RNO-416482; G alpha (12/13) signalling events.
DR   Reactome; R-RNO-416572; Sema4D induced cell migration and growth-cone collapse.
DR   Reactome; R-RNO-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-RNO-5627117; RHO GTPases Activate ROCKs.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-8980692; RHOA GTPase cycle.
DR   Reactome; R-RNO-9013026; RHOB GTPase cycle.
DR   Reactome; R-RNO-9013407; RHOH GTPase cycle.
DR   Reactome; R-RNO-9013422; RHOBTB1 GTPase cycle.
DR   Reactome; R-RNO-9696264; RND3 GTPase cycle.
DR   SABIO-RK; Q63644; -.
DR   PRO; PR:Q63644; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0032059; C:bleb; IEA:UniProtKB-SubCell.
DR   GO; GO:0005814; C:centriole; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0010494; C:cytoplasmic stress granule; ISO:RGD.
DR   GO; GO:0005856; C:cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0001726; C:ruffle; ISS:UniProtKB.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0045202; C:synapse; IDA:SynGO.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0072518; F:Rho-dependent protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0031267; F:small GTPase binding; IMP:RGD.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0031032; P:actomyosin structure organization; IBA:GO_Central.
DR   GO; GO:0003383; P:apical constriction; ISO:RGD.
DR   GO; GO:0032060; P:bleb assembly; ISO:RGD.
DR   GO; GO:0097746; P:blood vessel diameter maintenance; ISO:RGD.
DR   GO; GO:0007249; P:canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0030866; P:cortical actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0007010; P:cytoskeleton organization; IMP:RGD.
DR   GO; GO:0048598; P:embryonic morphogenesis; IBA:GO_Central.
DR   GO; GO:0001837; P:epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; ISO:RGD.
DR   GO; GO:0050900; P:leukocyte migration; ISO:RGD.
DR   GO; GO:0050901; P:leukocyte tethering or rolling; ISO:RGD.
DR   GO; GO:0022614; P:membrane to membrane docking; ISO:RGD.
DR   GO; GO:0000281; P:mitotic cytokinesis; IBA:GO_Central.
DR   GO; GO:0097049; P:motor neuron apoptotic process; ISO:RGD.
DR   GO; GO:0061157; P:mRNA destabilization; ISO:RGD.
DR   GO; GO:0051451; P:myoblast migration; ISS:UniProtKB.
DR   GO; GO:1902992; P:negative regulation of amyloid precursor protein catabolic process; ISO:RGD.
DR   GO; GO:1902430; P:negative regulation of amyloid-beta formation; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:1903347; P:negative regulation of bicellular tight junction assembly; ISO:RGD.
DR   GO; GO:2000672; P:negative regulation of motor neuron apoptotic process; ISO:RGD.
DR   GO; GO:0042326; P:negative regulation of phosphorylation; ISS:UniProtKB.
DR   GO; GO:0140058; P:neuron projection arborization; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; ISO:RGD.
DR   GO; GO:0090521; P:podocyte cell migration; ISS:UniProtKB.
DR   GO; GO:1900223; P:positive regulation of amyloid-beta clearance; ISO:RGD.
DR   GO; GO:0010508; P:positive regulation of autophagy; ISO:RGD.
DR   GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; ISO:RGD.
DR   GO; GO:1905205; P:positive regulation of connective tissue replacement; ISO:RGD.
DR   GO; GO:0035306; P:positive regulation of dephosphorylation; ISO:RGD.
DR   GO; GO:0051894; P:positive regulation of focal adhesion assembly; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:ARUK-UCL.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0032970; P:regulation of actin filament-based process; ISO:RGD.
DR   GO; GO:0110061; P:regulation of angiotensin-activated signaling pathway; ISO:RGD.
DR   GO; GO:1901888; P:regulation of cell junction assembly; IBA:GO_Central.
DR   GO; GO:0030334; P:regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:1903140; P:regulation of establishment of endothelial barrier; ISO:RGD.
DR   GO; GO:0045616; P:regulation of keratinocyte differentiation; ISO:RGD.
DR   GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0045664; P:regulation of neuron differentiation; ISO:RGD.
DR   GO; GO:0090128; P:regulation of synapse maturation; ISO:RGD.
DR   GO; GO:1900242; P:regulation of synaptic vesicle endocytosis; ISO:RGD.
DR   GO; GO:1990776; P:response to angiotensin; ISO:RGD.
DR   GO; GO:0071559; P:response to transforming growth factor beta; IGI:ARUK-UCL.
DR   GO; GO:0007266; P:Rho protein signal transduction; IMP:MGI.
DR   CDD; cd11639; HR1_ROCK1; 1.
DR   CDD; cd01242; PH_ROCK; 1.
DR   CDD; cd22250; ROCK_SBD; 1.
DR   CDD; cd05622; STKc_ROCK1; 1.
DR   Gene3D; 1.20.5.340; -; 1.
DR   Gene3D; 3.30.60.20; -; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 1.20.5.730; Single helix bin; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR011072; HR1_rho-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR050839; Rho-assoc_Ser/Thr_Kinase.
DR   InterPro; IPR020684; ROCK1/ROCK2.
DR   InterPro; IPR037310; ROCK1_HR1.
DR   InterPro; IPR015008; ROCK_Rho-bd_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR22988; MYOTONIC DYSTROPHY S/T KINASE-RELATED; 1.
DR   PANTHER; PTHR22988:SF33; RHO-ASSOCIATED PROTEIN KINASE 1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF08912; Rho_Binding; 1.
DR   PIRSF; PIRSF037568; Rho_kinase; 1.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 1.
DR   SUPFAM; SSF103652; G protein-binding domain; 1.
DR   SUPFAM; SSF90257; Myosin rod fragments; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS51860; REM_1; 1.
DR   PROSITE; PS51859; RHO_BD; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Apoptosis; ATP-binding; Cell membrane;
KW   Cell projection; Coiled coil; Cytoplasm; Cytoskeleton; Golgi apparatus;
KW   Kinase; Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q13464"
FT   CHAIN           2..1369
FT                   /note="Rho-associated protein kinase 1"
FT                   /id="PRO_0000086623"
FT   DOMAIN          76..338
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          341..409
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   DOMAIN          479..556
FT                   /note="REM-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01207"
FT   DOMAIN          949..1015
FT                   /note="RhoBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01206"
FT   DOMAIN          1133..1332
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   ZN_FING         1243..1298
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          368..727
FT                   /note="Interaction with FHOD1"
FT                   /evidence="ECO:0000250"
FT   REGION          707..946
FT                   /note="SHROOM3 binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q13464"
FT   REGION          998..1010
FT                   /note="RHOA binding"
FT                   /evidence="ECO:0000250"
FT   REGION          1115..1369
FT                   /note="Auto-inhibitory"
FT                   /evidence="ECO:0000250"
FT   COILED          422..692
FT                   /evidence="ECO:0000255"
FT   COILED          1011..1102
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        198
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         82..90
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         105
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   SITE            1113..1114
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13464"
FT   MOD_RES         1105
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13464"
FT   MOD_RES         1108
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70335"
FT   MOD_RES         1343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13464"
FT   VAR_SEQ         1..488
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_010449"
FT   VAR_SEQ         1369
FT                   /note="S -> RLMPSSPCRVGVGIDKWRSHRDRKREGLLTEDVPGSRLEKKLGRIGR
FT                   AARRNKDGADIQPCLDINDLLCMCRLVPLLGLPLVVTSGTAHVQFMHQVLVDR (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_010450"
FT   CONFLICT        1118..1133
FT                   /note="VGSACIPYLFIFYSSS -> E (in Ref. 2; AAP92621)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1283
FT                   /note="S -> C (in Ref. 2; AAP92621)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1296
FT                   /note="P -> S (in Ref. 2; AAP92621)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1316
FT                   /note="P -> S (in Ref. 2; AAP92621)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1334..1335
FT                   /note="KA -> NP (in Ref. 2; AAP92621)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1369 AA;  159626 MW;  E29B9456D348C9D0 CRC64;
     MSTGDSFETR FEKIDNLLRD PKSEVNSDCL LDGLDALVYD LDFPALRKNK NIDNFLSRYK
     DTINKIRDLR MKAEDYEVVK VIGRGAFGEV QLVRHKSTRK VYAMKLLSKF EMIKRSDSAF
     FWEERDIMAF ANSPWVVQLF YAFQDDRYLY MVMEYMPGGD LVNLMSNYDV PEKWARFYTA
     EVVLALDAIH SMGFIHRDVK PDNMLLDKSG HLKLADFGTC MKMNKEGMVR CDTAVGTPDY
     ISPEVLKSQG GDGYYGRECD WWSVGVFLYE MLVGDTPFYA DSLVGTYSKI MNHKNSLTFP
     DDNDISKEAK NLICAFLTDR EVRLGRNGVE EIKRHLFFKN DQWAWETLRD TVAPVVPDLS
     SDIDTSNFDD LEEDKGDEET FPIPKAFVGN QLPFVGFTYY SNRRYLPSAN PSENRSSSNV
     DKNVQESLQK TIYKLEEQLH NEMQLKDEME QKCRTSNIKL DKIMKELDEE GNQRRNLESA
     VSQIEKEKML LQHRINEYQR KVEQENEKRR NVENEVSTLK DQLEDLRKAS QSSQLANEKL
     TQLQKQLEEA NDLLRTESDT AVRLRKSHTE MSKSVSQLES LNRELQERNR MLENSKSQAD
     KDYYQLQAVL EAERRDRGHD SEMIGDLQAR ITSLQEEVKH LKHNLERVEG ERKEAQDMLN
     HSEKEKNNLE IDLNYKLKSI QQRLEQEVNE HKVTKARLTD KHQSIEEAKS VAMCEMEKKL
     KEEREAREKA ENRVVETEKQ CSMLDVDLKQ SQQKLEHLTE NKERLEDAVK SLTLQLEQES
     NKRILLQSEL KTQAFEADNL KGLEKQMKQE INTLLEAKRL LEFELAQLTK QYRGNEGQMR
     ELQDQLEAEQ YFSTLYKTQV KELKEEIEEK NRENLRKIQE LQSEKETLST QLDLAETKAE
     SEQLARGILE EQYFELTQES KKAASRNRQE ITDKDHTVSR LEEANNALTK DIELLRKENE
     ELNERMRTAE EEYKLKKEEE ISNLKAAFEK NISTERTLKT QAVNKLAEIM NRKDFKIDRK
     KANTQDLRKK EKENRKLQLE LNQEREKFNQ MVVKHQKELN DMQAQLVEEC THRNELQMQL
     ASKESDIEQL RAKLLDLSDS TSVASFPSAD ETDGNLPVGS ACIPYLFIFY SSSSRIEGWL
     SVPNRGNIKR YGWKKQYVVV SSKKMLFYND EQDKEQSSPS MVLDIDKLFH VRPVTQGDVY
     RAETEEIPKI FQILYANEGE CRKDIEVEPV QQGEKTNFQN HKGHEFIPTL YHFPANCEAC
     AKPLWHVFKP PPALECRRCH VKSHRDHLDK KEDLIPPCKV SYDVTSARDM LLLACPQDEQ
     KKWVTHLVKK IPKKAPSGFV RASPRTLSTR STANQSFRKV VKNTSGKTS
//
